Alectinib HCl supplier & exporter
Product Description
| API name | Alectinib HCl |
| CAS Number | 1256589-74-8 |
| Therapeutic Category | Anticancer, Antineoplastic |
| Route of Administration | Capsule |
| Regulatory Documents | TECH PACK, DMF |
Trader & Wholesaler of Alectinib HCl
Mechanism of Action:
Alectinib hydrochloride is an ALK kinase inhibitor, which inhibits ALK phosphorylation and ALK-media- ted activation of the downstream signaling proteins STAT3 and AKT, and decreases tumor cell viability in multiple cell lines harboring ALK fusions,
Drug Indications:
Alectinib HCl as monotherapy is indicated for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).